$52.00
-0.33-0.63%
Last update: Nov 11, 10:03 AM
First Tracks Biotherapeutics Inc
TRAXNASDAQ
First Tracks Biotherapeutics rose 168.4% from $19.50 to a 1-year high of $52.33, ahead of the S&P 500's +13.8%. Its worst day was Apr 20 (−17.4%), and its low came Jun 3 at $15.32.
Apr 6, 2026 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
First Tracks Biotherapeutics shares rose 27.4%, while the S&P 500 rose 2.5%.
+27.4% · S&P 500 +2.5%
First Tracks Biotherapeutics closed at its lowest level of the year, 21.4% below where the year started.
Story events cover the past 12 months · Times ET
−5.1% · S&P 500 −0.7%
First Tracks Biotherapeutics shares rose 56.0%, while the S&P 500 rose 0.8%.
+56.0%, the year's best day · S&P 500 +0.8%
EPS of $-0.95 was reported on $0.00 revenue.
−4.6% · S&P 500 +0.7%
EPS of $-0.88 beat the $-0.89 estimate on $0.00 revenue.
+5.8% · S&P 500 +1.7%
Where it ended: a 1-year high close of $52.33 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 12, 2027 (EPS est. $-0.73).
Nothing in the past 12 months.
All TRAX dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TRAX and SPY from Benzinga historical bars. Not investment advice.
